Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in Net LoansChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Amortizatization of Intangibles (2024 - 2025)

Abvc Biopharma (ABVC) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $208252.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles rose 256.9% year-over-year to $208252.0, compared with a TTM value of $479504.0 through Dec 2025, up 183.9%, and an annual FY2025 reading of $479504.0, up 183.9% over the prior year.
  • Amortizatization of Intangibles was $208252.0 for Q4 2025 at Abvc Biopharma, up from $90190.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $208252.0 in Q4 2025 and bottomed at -$132728.0 in Q4 2024.